Financhill
Back

PDS Biotechnology Quote, Financials, Valuation and Earnings

PDS Biotechnology Price Quote

$3.83
+0.11 (+2.96%)
(Updated: May 3, 2024 at 6:55 PM ET)

PDS Biotechnology Key Stats

Buy
55
PDS Biotechnology (PDSB) is a Buy

Day range:
$3.57 - $3.74
52-week range:
$2.59 - $10.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.22%

Volume:
329.1K
Avg. volume:
977.6K
1-year change:
-37.16%
Market cap:
$136.4M
Revenue:
$0
EPS:
$-1.39

How Much Does PDS Biotechnology Make?

Data Unavailable

Is PDS Biotechnology Growing As A Company?

Data Unavailable

PDS Biotechnology Stock Price Performance

What Is PDS Biotechnology 52-Week High & Low?

PDS Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PDS Biotechnology?

  • How Much Debt Does PDS Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does PDS Biotechnology Have?
    Cash and short term investments quarterly total is $56.6M
  • What Is PDS Biotechnology’s Book Value Per Share?
    Book value per share is 0.79

Is PDS Biotechnology Cash Flow Positive?

  • What Is PDSB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.6M
  • What Is PDS Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $16.4M
  • What Is PDS Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

PDS Biotechnology Return On Invested Capital

Data Unavailable

PDS Biotechnology Earnings Date & Stock Price

PDS Biotechnology Competitors

PDS Biotechnology Dividend Yield

Data Unavailable

PDS Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.27%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.40
Upside from Last Price: 287.1%

Major Shareholders

  • How many PDSB shares are owned by institutional investors?
    12.4M PDSB shares are owned by institutional investors
  • How many PDSB shares are owned by insiders?
    3M PDSB shares are owned by insiders